CN111955720A - Special postpartum lactation-promoting diet for puerpera and preparation method thereof - Google Patents
Special postpartum lactation-promoting diet for puerpera and preparation method thereof Download PDFInfo
- Publication number
- CN111955720A CN111955720A CN202010665559.1A CN202010665559A CN111955720A CN 111955720 A CN111955720 A CN 111955720A CN 202010665559 A CN202010665559 A CN 202010665559A CN 111955720 A CN111955720 A CN 111955720A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- root
- probiotics
- bifidobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 235000005911 diet Nutrition 0.000 title claims abstract description 12
- 230000037213 diet Effects 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 81
- 235000013305 food Nutrition 0.000 claims abstract description 50
- 230000006651 lactation Effects 0.000 claims abstract description 48
- 239000006041 probiotic Substances 0.000 claims abstract description 48
- 235000018291 probiotics Nutrition 0.000 claims abstract description 48
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 22
- 239000011707 mineral Substances 0.000 claims abstract description 22
- 235000010755 mineral Nutrition 0.000 claims abstract description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 20
- 229940088594 vitamin Drugs 0.000 claims abstract description 18
- 229930003231 vitamin Natural products 0.000 claims abstract description 18
- 235000013343 vitamin Nutrition 0.000 claims abstract description 18
- 239000011782 vitamin Substances 0.000 claims abstract description 18
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 15
- 150000001413 amino acids Chemical class 0.000 claims abstract description 14
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001556 precipitation Methods 0.000 claims abstract description 11
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 9
- 230000001737 promoting effect Effects 0.000 claims description 46
- 239000000284 extract Substances 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 24
- 235000019197 fats Nutrition 0.000 claims description 17
- 241000186660 Lactobacillus Species 0.000 claims description 13
- 241000283966 Pholidota <mammal> Species 0.000 claims description 13
- 241000208340 Araliaceae Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 229940039696 lactobacillus Drugs 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 241000186000 Bifidobacterium Species 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 235000019198 oils Nutrition 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- -1 compound amino acid Chemical class 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 244000189799 Asimina triloba Species 0.000 claims description 8
- 235000006264 Asimina triloba Nutrition 0.000 claims description 8
- 235000009467 Carica papaya Nutrition 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- 102000015636 Oligopeptides Human genes 0.000 claims description 8
- 108010038807 Oligopeptides Proteins 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 8
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 7
- 240000007651 Rubus glaucus Species 0.000 claims description 7
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 7
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 7
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 7
- 244000178320 Vaccaria pyramidata Species 0.000 claims description 7
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims description 7
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- 235000011477 liquorice Nutrition 0.000 claims description 7
- 241000213006 Angelica dahurica Species 0.000 claims description 6
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 6
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 6
- 229930182816 L-glutamine Natural products 0.000 claims description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 6
- 244000274050 Platycodon grandiflorum Species 0.000 claims description 6
- 241000405414 Rehmannia Species 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 6
- 240000001417 Vigna umbellata Species 0.000 claims description 6
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 6
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 241000722953 Akebia Species 0.000 claims description 5
- 241001061264 Astragalus Species 0.000 claims description 5
- 240000006927 Foeniculum vulgare Species 0.000 claims description 5
- 241000208682 Liquidambar Species 0.000 claims description 5
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims description 5
- 240000002624 Mespilus germanica Species 0.000 claims description 5
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 5
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 5
- 241000243142 Porifera Species 0.000 claims description 5
- 244000046146 Pueraria lobata Species 0.000 claims description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 5
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 5
- 235000013325 dietary fiber Nutrition 0.000 claims description 5
- 235000012461 sponges Nutrition 0.000 claims description 5
- 235000020238 sunflower seed Nutrition 0.000 claims description 5
- 210000004233 talus Anatomy 0.000 claims description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims description 4
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 4
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 4
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 4
- 240000001980 Cucurbita pepo Species 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 241000208688 Eucommia Species 0.000 claims description 4
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 4
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 4
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 4
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 4
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 4
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 4
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 235000003956 Luffa Nutrition 0.000 claims description 4
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 235000012874 Phaseolus calcaratus Nutrition 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 235000017803 cinnamon Nutrition 0.000 claims description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 4
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 235000021119 whey protein Nutrition 0.000 claims description 4
- 241000045403 Astragalus propinquus Species 0.000 claims description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 3
- 241000675108 Citrus tangerina Species 0.000 claims description 3
- 235000002176 Foeniculum vulgare var vulgare Nutrition 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 241000756137 Hemerocallis Species 0.000 claims description 3
- 241000212322 Levisticum officinale Species 0.000 claims description 3
- 241000488974 Loranthus Species 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 235000006751 Platycodon Nutrition 0.000 claims description 3
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 3
- 241000316342 Taxillus Species 0.000 claims description 3
- 244000290970 Tetrapanax papyrifer Species 0.000 claims description 3
- 239000001645 levisticum officinale Substances 0.000 claims description 3
- 229930189914 platycodon Natural products 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- 241001127714 Amomum Species 0.000 claims description 2
- 241000007126 Codonopsis pilosula Species 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 240000001008 Dimocarpus longan Species 0.000 claims description 2
- 235000000235 Euphoria longan Nutrition 0.000 claims description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 239000002211 L-ascorbic acid Substances 0.000 claims description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 2
- 241000112528 Ligusticum striatum Species 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 229960002079 calcium pantothenate Drugs 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 claims description 2
- 229960004874 choline bitartrate Drugs 0.000 claims description 2
- 239000011666 cyanocobalamin Substances 0.000 claims description 2
- 229960002104 cyanocobalamin Drugs 0.000 claims description 2
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 2
- 235000018927 edible plant Nutrition 0.000 claims description 2
- 239000011706 ferric diphosphate Substances 0.000 claims description 2
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 2
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 2
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 244000237330 gutta percha tree Species 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 2
- 229960000869 magnesium oxide Drugs 0.000 claims description 2
- 235000012245 magnesium oxide Nutrition 0.000 claims description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 2
- 230000003071 parasitic effect Effects 0.000 claims description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 2
- 229960000342 retinol acetate Drugs 0.000 claims description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 2
- 235000019173 retinyl acetate Nutrition 0.000 claims description 2
- 239000011770 retinyl acetate Substances 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 239000011781 sodium selenite Substances 0.000 claims description 2
- 229960001471 sodium selenite Drugs 0.000 claims description 2
- 235000015921 sodium selenite Nutrition 0.000 claims description 2
- 235000013826 starch sodium octenyl succinate Nutrition 0.000 claims description 2
- 239000001334 starch sodium octenyl succinate Substances 0.000 claims description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 2
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 229940074410 trehalose Drugs 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- 235000008939 whole milk Nutrition 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 240000007890 Leonurus cardiaca Species 0.000 claims 2
- 244000050983 Luffa operculata Species 0.000 claims 2
- 240000001949 Taraxacum officinale Species 0.000 claims 2
- 244000280244 Luffa acutangula Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 42
- 238000000034 method Methods 0.000 abstract description 30
- 210000000952 spleen Anatomy 0.000 abstract description 23
- 210000002784 stomach Anatomy 0.000 abstract description 19
- 238000010521 absorption reaction Methods 0.000 abstract description 14
- 235000001014 amino acid Nutrition 0.000 abstract description 14
- 150000001720 carbohydrates Chemical class 0.000 abstract description 14
- 235000014633 carbohydrates Nutrition 0.000 abstract description 14
- 238000002137 ultrasound extraction Methods 0.000 abstract description 13
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 10
- 239000012535 impurity Substances 0.000 abstract description 8
- 238000001694 spray drying Methods 0.000 abstract description 8
- 230000001954 sterilising effect Effects 0.000 abstract description 8
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 8
- 241000411851 herbal medicine Species 0.000 abstract description 7
- 210000000936 intestine Anatomy 0.000 abstract description 7
- 239000000447 pesticide residue Substances 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 6
- 230000033001 locomotion Effects 0.000 abstract description 6
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 230000035606 childbirth Effects 0.000 abstract description 3
- 230000001983 lactogenic effect Effects 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000035755 proliferation Effects 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- 208000004104 gestational diabetes Diseases 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 description 49
- 239000008280 blood Substances 0.000 description 49
- 230000006870 function Effects 0.000 description 25
- 238000000605 extraction Methods 0.000 description 24
- 208000019395 Lactation disease Diseases 0.000 description 22
- 206010042576 Suppressed lactation Diseases 0.000 description 22
- 210000001035 gastrointestinal tract Anatomy 0.000 description 20
- 230000000968 intestinal effect Effects 0.000 description 20
- 239000000463 material Substances 0.000 description 20
- 239000008267 milk Substances 0.000 description 19
- 210000004080 milk Anatomy 0.000 description 19
- 230000017531 blood circulation Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- 235000013336 milk Nutrition 0.000 description 18
- 230000001976 improved effect Effects 0.000 description 15
- 230000001105 regulatory effect Effects 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 13
- 239000000686 essence Substances 0.000 description 12
- 235000015097 nutrients Nutrition 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 230000036039 immunity Effects 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000003094 microcapsule Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229940126680 traditional chinese medicines Drugs 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 210000004051 gastric juice Anatomy 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 241000207925 Leonurus Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 229960002743 glutamine Drugs 0.000 description 4
- 210000004347 intestinal mucosa Anatomy 0.000 description 4
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 229960004452 methionine Drugs 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 206010000234 Abortion spontaneous Diseases 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- 244000302544 Luffa aegyptiaca Species 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 229960003121 arginine Drugs 0.000 description 3
- 229940107666 astragalus root Drugs 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 3
- 229940107187 fructooligosaccharide Drugs 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960002885 histidine Drugs 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229960003646 lysine Drugs 0.000 description 3
- 208000015994 miscarriage Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 208000000995 spontaneous abortion Diseases 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000268590 Euryale ferox Species 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 206010060710 Galactostasis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000219138 Luffa Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000008599 Poria cocos Nutrition 0.000 description 2
- 244000197580 Poria cocos Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000037006 agalactosis Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 2
- 229960003040 rifaximin Drugs 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000141331 Amomum villosum Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000146029 Lindera aggregata Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 240000000038 Ziziphus mauritiana Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000003629 gastrointestinal hormone Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000000569 greater omentum Anatomy 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 125000003203 triacylglycerol group Chemical group 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/32—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using phonon wave energy, e.g. sound or ultrasonic waves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/145—Gasseri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a special postpartum lactogenic diet for puerperae and a preparation method thereof; the product is prepared by adopting a plurality of medicinal and edible herbal medicines which are compatible for postpartum lactation promotion, adopting semi-bionic or biological enzymolysis and ultrasonic extraction, vacuum concentration, alcohol precipitation or ultrafiltration to remove impurities and pesticide residues, preparing herbal essence by an integrated innovative spray drying method, and adding a plurality of probiotics, amino acids, prebiotics, short peptides, carbohydrates, compound vitamins and compound minerals for mixing; the medical formula food for gestational diabetes can promote the proliferation of probiotics, regulate the microecological balance in intestines, promote the absorption of trace elements and enhance the movement function of spleen and stomach, and has the unique advantage of integrating the triple effects of diet therapy, prevention and conditioning; in addition, the invention also provides a preparation method of the medical formula food for the gestational diabetes, which solves the world technical problem of the combined action of the traditional Chinese medicine sterilization function and the probiotics; the special food is suitable for people who can promote lactation after childbirth.
Description
Technical Field
The invention belongs to the technical field of medicinal and edible formulas and food, and particularly relates to lactation promoting full-nutrition formula food prepared by organically combining the traditional Chinese medicine marrow theory of medicinal and edible traditional Chinese medicines with multiple probiotics and adding protein short peptide, prebiotics, amino acid, carbohydrate, compound vitamin and compound mineral as auxiliary materials and a preparation method thereof.
Background
The postpartum hypogalactia refers to the situation that the lactation amount of a puerpera in the lactation period after childbirth is low or no lactation exists, the requirement of nursing babies cannot be met, and the postpartum hypogalactia is called as 'lactation failure' or 'lactation deficiency' in traditional Chinese medicine; it is mostly produced in the 2 nd to 15 th day after delivery or in the whole lactation period, and accounts for about 22.2% of all puerperae; lactation promotion is a Chinese medical treatment method, also called lactation promotion and lactation reduction, is a method for treating postpartum hypogalactia, and achieves the purpose of promoting breast milk secretion by a scientific method; traditional Chinese medicine has a long history of postpartum hypogalactia, accumulates abundant experiences, for example, Song Dynasty Chen has a standing effective prescription of hypogalactia juice from Ming & ltLing Yuan Fang & gt from "big and full effective prescription for women"; the traditional Chinese medicine lactation promotion method is a traditional lactation promotion method in traditional Chinese medicine, is also a main therapy for true hypogalactia, forms a relatively complete theoretical system, and obtains better curative effect in clinical practice; the breast milk contains more than 300 immune substances, such as various secretory immunoglobulin, growth promotion factors, intestinal hormones, active enzymes, phagocytes, lymphocytes and the like, can enhance the immunity of the infant, is rich in nutrition, is suitable for the digestion and absorption of the infant, and is most beneficial to the growth and development of the infant; the breast feeding can promote the emotional communication of the mother and the baby, promote the intelligent development of the baby, is beneficial to the health of the mother, can stimulate the uterine contraction of the lying-in woman by sucking the milk of the baby, reduce the postpartum hemorrhage, inhibit the ovulation, delay the menstruation resurgence and reduce the occurrence of breast cancer and ovarian cancer; the prevention and treatment of postpartum hypogalactia has important significance for improving the rate of breast feeding;
the "all sources of disease" cloud: "postpartum agalactia, i.e. the lack of body fluid and blood during childbirth; the Jingxiaoyanbao (effective birth treasures) considers that qi and blood deficiency and irregular meridians are the causes of hypogalactia; chen is not selected in the "three causes of extreme syndrome and syndrome in the" Fang Lun "in the theory of deficiency and excess: two kinds of puerpera have the symptoms of failure of mammary vessels, failure of qi and blood due to congestion, and failure of blood, deficiency of blood and weak qi; deficiency when tonifying and excess when dredging "; therefore, the medicine which can nourish blood and yin, and promote qi and blood circulation is selected to treat postpartum hypogalactia;
due to the influence of various factors such as the short pace of life, the food quality, the environmental pollution, the gradual increase of the pregnancy age, the change of the living habits of people and the like in the modern society, the incidence of postpartum hypogalactia in China has a gradual rising trend in recent years; the traditional Chinese medicine composition can be used for timely and effectively treating postpartum hypogalactia patients, improving hypogalactia symptoms, meeting the requirement of feeding infants, and having important significance for improving population quality; modern medicine has effective treatment measures and treatment medicines for postpartum hypogalactia, and traditional Chinese medicine has more literature reports on postpartum hypogalactia treatment of puerpera; according to the traditional Chinese medicine theory, the qi and blood flow downwards during pregnancy of the female is used for nourishing the fetus, and the qi and blood flow upwards after delivery is used for promoting lactation; milk is generated by blood and depends on qi; the lack of lactation is mostly caused by qi and blood deficiency and obstruction of mammary collaterals; the woman is weak in qi and blood, and can not supplement qi and blood in time due to excessive qi consumption, excessive blood loss or weakness of spleen and stomach function in the delivery process, the qi and blood are generated and generated passively, the qi and blood are not supplemented in time, and the milk generation is lack of source, so that little milk is produced or the milk can not be discharged; fu Qing Master Ladies, which means that women can be confined in the milk duct without dripping after delivery and know that the qi and blood are both dry; furu is formed by qi and blood, and cannot produce milk without blood and qi; women use the liver as the innate root, the liver stores blood and regulates flow of qi, and the breast and hypochondriac area are distributed by the liver meridian, so the milk secretion is related to the flow of liver qi; the lactation promoting prescription helps to improve the qi and blood weakness of the organism of the lying-in woman, invigorates qi and generates blood, and dredges collaterals and promotes lactation; the body fluid and blood milk are homologous, generated by the essence of the food which is absorbed by the spleen and the stomach in the later day, and the prescription medicine can simultaneously tonify the spleen and the stomach, promote blood circulation, remove meridian obstruction and promote lactation;
the research result shows that the lactation promoting full-nutrition formula food can obviously increase the lactation amount of the lying-in women; in the prescription, the angelica, the donkey-hide gelatin, the ginseng and the astragalus root enrich the blood, nourish the blood and promote the circulation of blood; medulla Tetrapanacis and radix Rhapontici have effects of dispersing stagnated liver qi, regulating qi-flowing, dredging collaterals and promoting lactation; the liquorice passes through twelve meridians, eliminates pathogenic heat, strengthens bones and muscles, strengthens spleen and stomach, has the property of neutralization, has the functions of regulating and tonifying, coordinates various medicines, does not compete, and regulates cold, cool and warm heat of the various medicines, thereby being a guiding medicine of the whole formula; the whole formula of the medicine has assistant and assistant effects, for example, donkey-hide gelatin enriches blood, stops bleeding, nourishes yin and moistens dryness, astragalus invigorates qi, encourages qi and blood circulation, invigorates middle-jiao and earth, warms and nourishes spleen and stomach, uses astragalus to invigorate spleen and stomach qi greatly, resources of blood generation, tonifies qi and produces milk; donkey-hide gelatin is used together with qi-tonifying and blood-nourishing herbs such as Dang Gui and Huang Qi to tonify qi and blood, so that doctors think that qi is invisible and blood is visible; it is difficult to grow rapidly in the visible state and must grow with invisible qi; radix astragali is used in radix Angelicae sinensis, and is combined with Ginseng radix to treat blood deficiency, lassitude and asthenia; in the formula, the ginseng can tonify primordial qi, the Chinese angelica has the functions of promoting blood circulation and relieving fatigue, and the ginseng and the Chinese angelica have the functions of enriching and promoting blood circulation; the dandelion is used for removing heat toxin and relieving food toxicity, the uniflower swisscentaury root is bitter in taste and can reduce diarrhea, the stomach meridian of a person is dredged, the stomach qi can reach the stomach and can reduce milk, and the dandelion is matched with the astragalus root and has the functions of dredging the meridian and reducing milk; the medicines of the whole formula are combined with biochemical sources to tonify qi and produce blood, and the effects of dredging collaterals and promoting lactation, promoting diuresis and promoting lactation, strengthening spleen and promoting lactation, regulating blood and producing lactation are achieved together;
the homology of medicine and food is one of the most valuable contributions to human in Chinese original medicine; traditional Chinese medicine always emphasizes that the medical therapy is inferior to the food therapy, and the food therapy becomes the best choice for modern people to pursue truthful and healthy diet; the pain can be removed in the process of enjoying the delicious food, and the suffering of injection, medicine taking and even operation can be avoided; for special nutritional food, the food is correspondingly regulated, developed and applied in developed countries such as the United states, European Union and the like; and the total nutrient food is definitely specified in national food safety standard GB29922-2013 general rules for formula food for special medical applications: 2.1.1 Total nutrient formula food: the special medical formula food can be used as a single nutrient source to meet the nutritional requirements of target people; 2.1.2 specific total nutrient formula: the special medical formula food can be used as a single nutrient source to meet the nutritional requirements of target people under specific diseases or medical conditions;
researches prove that a close relationship exists between spleen and normal flora of gastrointestinal tract in traditional Chinese medicine, lactation promotion is closely related to imbalance of the flora of intestinal tract, the spleen deficiency syndrome is a syndrome reflecting insufficiency of physiological functions of spleen and stomach of an organism, when the gastrointestinal function of the organism is abnormal, the microecological system of the intestinal tract is seriously damaged, conditional pathogenic bacteria such as escherichia coli and the like are proliferated in a large quantity, and the quantity of probiotics such as bifidobacterium, lactobacillus and the like is obviously reduced; meanwhile, the dysbacteriosis adversely affects the absorption of organisms on nutrient substances, reduces the immunity of the organisms, weakens the barrier function of intestinal tracts, and further aggravates diseases, and the traditional Chinese medicine considers that: the spleen (namely a digestive system) is the acquired root, the gastrointestinal health is the healthy root, 99 percent of nutrition of a human body needs to be absorbed by an intestinal tract, and intestinal diseases are also sources of ten thousands of diseases; but with age the proportion of beneficial flora (probiotics) in the intestine decreases progressively; for example, the bifidobacterium accounts for 98 percent in the infant period, is reduced to 10 percent by the middle age and only accounts for 5 percent after the age of 65; the older the person is, the fewer the probiotics are, the gradually decreased intestinal function is, and more researches show that the normal flora has various irreplaceable effects on the aspects of human digestion, immunity, disease resistance and the like; the change of the intestinal flora composition is closely related to the occurrence and development of various diseases, particularly intestinal diseases, and the following clinical researches find that: the probiotics can play a role in regulating intestinal flora and controlling intestinal inflammation, and is a safe and effective intervention and regulation method;
direct oral administration of probiotics has certain effect, but as the probiotics I can not be fixedly planted in intestinal tracts, stays and occupies little space, is easy to lose, harmful bacteria are easy to relapse after stopping administration, relevant patients need to take the probiotics for a long time, the treatment period is long, and the relapse rate is very high after the probiotics I are often used; in order to shorten the treatment period of related patients and reduce the recurrence rate after drug withdrawal, the team strives to seek a 'medicine and food homologous traditional Chinese medicine' compound for improving the field planting of probiotics in the intestinal tract through the key technical research on the planting mechanism of the probiotics in the intestinal tract in three years, and considers a plurality of key elements of the field planting of the probiotics in the intestinal tract: based on the factors, the group selects suitable food materials from dozens of traditional Chinese medicines which are homologous in medicine and food, and after extracts of traditional Chinese medicine components which are homologous in medicine and food, such as Chinese angelica, ginseng, gorgon euryale seed, tuckahoe, lindera aggregate leaf, liquorice and the like, as well as stachyose, isomaltooligosaccharide, yeast, L-glutamine and the like are added, the group has a strong colonization effect on exogenous probiotics, and provides an experimental basis for the selection of the formula of the probiotics in the intestinal microecological preparation;
at present, a composite formula consisting of food-borne short peptides serving as main raw materials, extracts of ginger, cinnamon, gordon euryale seed, poria cocos, liquorice and the like which can be used as medicine and food, compound vitamins and mineral substances is favorably adopted in the market, and a product using probiotics as the main raw materials is also provided, but no specific full-nutrition formula food or a special postpartum lactation promoting dietary product which is prepared by taking various traditional Chinese medicine extract essences, various probiotics and short peptides which can be used as the main raw materials and prebiotics, carbohydrates, amino acids, various vitamins and various mineral substances as auxiliary materials in combination with the physical characteristics of a lactation promoting patient is found;
in recent years, some new traditional Chinese medicine oral liquid extraction processes are applied, so that the extraction efficiency and the quality of medicine components are improved, and the new processes comprise supercritical fluid extraction, enzymolysis extraction, ultrasonic extraction and the like; however, after intensive research, it is found that the supercritical fluid extraction process has high cost, high operation safety requirement, uncomplicated enzymolysis extraction process, high cost, and the extraction conditions must be paid attention to maintain the activity of the biological enzyme in the operation details, otherwise, the extraction effect is affected; however, the existing extraction technology is mostly improved on the basis of the traditional water extraction and alcohol precipitation method, and the problems on concentration and filtration are not solved, so that the continuous exploration is needed, the extraction efficiency of the traditional Chinese medicine oral liquid is improved, and the traditional Chinese medicine production and preparation method with higher drug effect is realized; in recent years, some new traditional Chinese medicine oral liquid extraction processes are applied, so that the extraction efficiency and the quality of medicine components are improved, and the new processes comprise supercritical fluid extraction, enzymolysis extraction, ultrasonic extraction and the like; however, after intensive research, it is found that the supercritical fluid extraction process has high cost, high operation safety requirement, uncomplicated enzymolysis extraction process, high cost, and the extraction conditions must be paid attention to maintain the activity of the biological enzyme in the operation details, otherwise, the extraction effect is affected; however, the existing extraction technology is mostly improved on the basis of the traditional water extraction and alcohol precipitation method, and the problems on concentration and filtration are not solved, so that continuous exploration is needed, the extraction efficiency of the traditional Chinese medicine oral liquid is improved, and the production and preparation method of the traditional Chinese medicine oral liquid with higher drug effect is realized;
the development of modern science has proven that: the Chinese herbal medicine can change the composition of intestinal flora and recover the imbalance of the intestinal flora, and the intestinal flora can improve the bioavailability of the Chinese herbal medicine; but the flavonoids and the alkaloids of the traditional Chinese medicine have very strong bactericidal functions, namely the flavonoids and the alkaloids of the traditional Chinese medicine have very strong bactericidal (including probiotics) functions in the intestinal tract, and the world technical problem of the combined action of the bactericidal functions of the traditional Chinese medicine and the probiotics is solved.
Object of the Invention
The invention aims to creatively combine various probiotics for improving the immunity of postpartum hypogalactia patients and extracts of a compound of traditional Chinese medicines with homology of medicine and food on the basis of a disease treatment method inherited by the theory of essence of traditional Chinese medicine, adds short peptides, amino acids, carbohydrates, various vitamins and various mineral substances as auxiliary materials, can supplement nutrients necessary for the lactation patients and improve the nutritional status of organisms, can also utilize functional factors in the medicine-food dual-purpose Chinese herbal medicines to regulate the organism functions, has small toxic and side effects, is safe and effective, but flavonoids and alkaloids in the traditional Chinese medicines have very strong sterilization functions, namely flavonoids and alkaloids in the traditional Chinese medicines in the intestinal tract have very strong sterilization (including probiotics) functions, and the technology of combining the sterilization function of the traditional Chinese medicines and the probiotics is obtained through the technical attack of more than 20 years, the technical problem of the world is solved; and develops a special postpartum lactogenic diet which is easy to accept by people and is suitable for lactogenic patients to eat.
The integrated innovative preparation method comprises the following steps: step 1, semi-bionic ultrasonic extraction is carried out, accelerated motion of medicinal material substance molecules is realized by utilizing the characteristics of ultrasonic waves, and then the penetration force of liquid medicine is improved, so that the extraction efficiency is improved, the ultrasonic extraction is a physical extraction process, the chemical properties and the structures of active ingredients in medicinal materials are generally not changed, step 2, after the extract is subjected to vacuum concentration, impurities and pesticide residues are removed by an alcohol precipitation or ultrafiltration method to purify the extract, step 3, a herbal essence microencapsulation protection technology is manufactured by an integrated innovative method of spray drying, and the inactivation of high temperature and strong acid gastric juice to probiotics in an oral taking process is effectively solved; the invention adopts a three-layer protein deep-buried microcapsule technology, integrates an innovative preparation method with the aim of the invention, and adopts a preparation process of uniformly mixing microencapsulated traditional Chinese medicine extracts, so as to solve the world technical problem of the combined action of the traditional Chinese medicine sterilization function and probiotics.
Disclosure of Invention
The research and development team combines the constitutional features of postpartum hypogalactia patients according to the requirements of the general rules of food formula for special medical use, integrates the research results of advanced physiology, medicine, nutriology, clinical application and the like of the current American Harvard university, adopts more than 2 kinds of extract essences of traditional Chinese medicine with dual purposes of medicine and food, a plurality of probiotics and short peptide as main raw materials according to the essence theory of the traditional Chinese medicine (the principle that the liver, the spleen and the kidney are concocted together) of ' tonifying while removing center and ' balanced nursing ', prebiotics, carbohydrates, amino acids, various vitamins and mineral matter auxiliary materials are used as a single nutrient source to meet the nutritional requirements of postpartum hypogalactia patients, and the nutritional formula food, the special diet, the specific total nutrient formula food or the non-total nutrient formula food (combined composite formula) which can tonify qi, activate blood circulation, invigorate spleen, invigorate stomach, dredge collaterals, promote lactation, regulate blood circulation, promote lactation and improve immunity is also provided;
the main components of the formula of the invention
1. Traditional Chinese medicine extract: the traditional Chinese medicine extract is prepared by using functional factors in medicinal and edible Chinese herbal medicines to regulate body functions and enhance resistance according to the principle that physical characteristics of postpartum hypogalactia patients are in concordance with three viscera of liver, spleen and kidney in the theory of traditional Chinese medicine, and selecting the following medicines for compatibility; wherein: the Chinese herbal medicine lactation promoting prescription, WANGBAIXING, is called as the "blood circulation promoting and lactation promoting" Shenpin from Ben Cao gang mu "; the pangolin enters two channels of jueyin and yangming, smells smell of qi and flees, can reach the channels and collaterals, dredges qi and blood to cause lactation, combines the cowherb seed and the pangolin, and enhances the curative effect; li Shizhen has been said in Ben Cao gang mu: pangolin scales, cowherb seeds and breast growing fluid taken by women; astragalus membranaceus is a product for tonifying qi; the angelica is sweet, pungent and warm in nature, enters liver, heart and spleen channels, is sweet, warm and blood-replenishing, and is a key medicine for replenishing blood, so that the angelica not only can nourish blood to help milk source formation, but also can activate blood to smooth milk; akebia quinata can clear the fire in heart channel upwards, purge heat in small intestine downwards, make damp-heat pathogen descend and flow out from urine, so it has the functions of purging fire and inducing diuresis, and can promote blood circulation and articulation, dredge meridian obstruction and make breast milk; loofah sponge is capable of relieving chest stuffiness and dissipating stagnation; the rhizoma ligustici wallichii is a blood-qi-regulating medicine and is used together with the angelica, so that the effects of nourishing blood and yin, promoting qi and blood circulation and regulating postpartum qi and blood are achieved; the uniflower swisscentaury root, radix Rhapontici, with bitter and cold properties, has the effects of clearing away heat and toxic materials, eliminating carbuncle and swelling and promoting lactation; ricepaperplant pith: the functions of clearing heat, promoting diuresis, promoting qi circulation and hypogalactia are achieved; the liquorice tonifies the spleen and the qi, and regulates the medicines; the medicines are combined to achieve the effects of dredging the channels and collaterals and promoting lactation; in the formula, angelica, donkey-hide gelatin, radix codonopsitis, ginseng and astragalus root enrich the blood, nourish the blood and promote blood circulation; medulla Tetrapanacis and radix Rhapontici have effects of dispersing stagnated liver qi, regulating qi-flowing, dredging collaterals and promoting lactation; the rhizoma ligustici wallichii is a blood-qi-regulating medicine and is used together with the angelica, so that the effects of nourishing blood and yin, promoting qi and blood circulation and regulating postpartum qi and blood are achieved; squama Manis Preparata has blood circulation promoting and stagnation resolving effects; stimulating the menstrual flow and promoting lactation; resolving carbuncle and dissipating hard mass; loranthus mulberry mistletoe is bitter and sweet in taste and neutral in nature; nourishing liver and kidney, strengthening tendons and bones, removing rheumatism, dredging channels and collaterals, benefiting blood, and preventing miscarriage; treating soreness of waist and knees, atrophy and weakness of tendons and bones, hemiplegia, tinea pedis, arthralgia due to wind-cold-dampness, fetal leakage, metrorrhagia, and puerperal agalactia; lulutong is bitter in taste and neutral in nature; dispelling pathogenic wind, activating collaterals, inducing diuresis, and dredging channels; can be used for treating arthralgia, numbness, spasm, edema, less milk, and amenorrhea; the prepared rehmannia root has the effects of enriching blood, nourishing yin, benefiting essence and filling marrow; eucommia bark has the effects of tonifying liver and kidney, strengthening tendons and bones and preventing miscarriage; the motherwort herb has the effects of promoting blood circulation to regulate menstruation, inducing diuresis to reduce edema, and clearing away heat and toxic materials; pawpaw has the effects of relaxing tendons, activating collaterals, harmonizing stomach and eliminating dampness; the Chinese dates have the effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves; corn stigma is wide in intestine and downward in qi; treating female lactation retention and galactostasis; the platycodon grandiflorum has the effects of dispersing lung qi, relieving sore throat, eliminating phlegm and expelling pus; the phaseolus calcaratus can induce diuresis to alleviate edema, detoxify and expel pus; fructus Amomi has effects of eliminating dampness, stimulating appetite, warming spleen, relieving diarrhea, regulating qi-flowing, and preventing miscarriage; the dried orange peel can regulate qi, invigorate spleen, eliminate dampness and reduce phlegm; cinnamon tonifies fire and strengthens yang, induces fire to return to original, dispels cold and relieves pain, and warms and dredges channels; fructus Rubi has effects in invigorating kidney, stopping nocturnal emission, reducing urination, nourishing liver, and improving eyesight; the yam has the effects of tonifying spleen and nourishing stomach, promoting the production of body fluid and benefiting lung, and tonifying kidney and arresting seminal emission; fructus Foeniculi has effects of dispelling cold, relieving pain, regulating qi-flowing and regulating stomach; honeysuckle flower has the effects of clearing away heat and toxic materials and dispelling wind and heat; radix Puerariae has effects of expelling pathogenic factors from muscles and skin, relieving fever, promoting fluid production, quenching thirst, dredging meridian passage; daylily has hemostatic, antiinflammatory, heat clearing away, dampness removing, digestion promoting, eyesight improving, and tranquilizing effects, and can be used for treating hematemesis, hematochezia, urinary obstruction, insomnia, and galactostasis; the medlar has the effects of nourishing liver and kidney, replenishing vital essence and improving eyesight; the medicines of the whole formula are combined with biochemical sources, so that the qi and blood are tonified, the effects of dredging collaterals and promoting milk, promoting diuresis and promoting milk, strengthening spleen and promoting milk, and regulating blood and producing milk are achieved, and the early lactation of a puerpera is promoted and the lactation amount is increased;
the traditional Chinese medicine extract is more than 6 or all of astragalus, processed pangolin, uniflower swisscentaury root, cowherb seed, Chinese taxillus twig, pangolin, beautiful sweetgum fruit, pilose asiabell root, akebia stem, prepared rehmannia root, szechuan lovage rhizome, eucommia bark, ricepaper pith, motherwort herb, donkey-hide gelatin, ginseng, Chinese angelica, towel gourd seed, towel gourd vegetable sponge, pawpaw, Chinese date, corn stigma, platycodon root, phaseolus calcaratus, amomum villosum, tangerine peel, cassia bark, raspberry, Chinese yam, common fennel fruit, honeysuckle flower, liquorice, dandelion, kudzuvine root;
2. prebiotics
The probiotic bacteria can promote intestinal colonization, intestinal convergence and reduce the intestinal pH environment, and can be used by most intestinal putrefying bacteria, but can promote the growth and reproduction of beneficial bacteria in human bodies, such as lactobacillus and bifidobacterium, so that the growth of the putrefying bacteria can be inhibited, and the normal functions of the intestinal tract can be improved and maintained; the long-term eating of the health food can delay aging, relieve constipation, improve immunity, relieve liver burden, improve nutrient absorption rate, and especially can improve the absorption of organisms on metal ions such as calcium, iron, zinc and the like; can selectively promote growth and reproduction of beneficial bacteria (bifidus and lactic acid), and can be metabolized into acidic products such as lactic acid and other organic acids, so as to reduce pH value in colon and inhibit growth of harmful bacteria in intestinal tract; the intestinal electrolyte in the small intestine is retained in the intestinal cavity to generate a hypertonic effect, and intestinal peristalsis is stimulated to cause laxation, so that the discharge of the endotoxin and other toxic substances in the intestinal tract is promoted, and the lactulose can also directly inactivate the endotoxin in the intestinal tract and reduce the pH value of the intestinal tract;
the prebiotics are 2 types;
a. has strong colonization effect on exogenous probiotics: several or all of rhizoma Dioscoreae, Ginseng radix, radix Angelicae sinensis, Glycyrrhrizae radix, radix Puerariae extract, stachyose, and yeast;
b. general prebiotics: one, several or all of lactose, brown sugar, isomaltooligosaccharide, fructo-oligosaccharide, soybean oligosaccharide and xylo-oligosaccharide;
the oligosaccharide is one, several or all of isomaltooligosaccharide, stachyose, fructo-oligosaccharide, soybean oligosaccharide and xylo-oligosaccharide;
3. short peptides
The oligopeptide is a small molecular protein separated and extracted from animal or plant protein by using a biological enzyme engineering technology, has the average molecular weight of below 1000Dalton, is easy to dissolve in water, is stable to acid and heat, can be directly absorbed without being digested, has high bioavailability, is superior to free amino acid and complete protein in absorption and utilization, can be applied to protein supplement food, is particularly suitable for people with low digestion and absorption capacity, is an excellent nitrogen source, and has a series of physiological activity functions besides the nutrition function: improving the digestive absorption function of small intestine, enhancing immunity, resisting oxidation, assisting in regulating blood sugar, assisting in regulating blood lipid, assisting in lowering blood pressure, resisting radiation, promoting mineral absorption, and enhancing the effect of functional factors in medicinal and edible Chinese herbal medicines;
the short peptide is one, several or all of marine fish oligopeptide, marine osteopeptide, soybean protein peptide, whey protein peptide, egg albumin peptide and wheat oligopeptide;
4. multiple probiotics
The probiotics can reach the intestinal tract through the strong acid environment of the stomach, so as to promote the proliferation of the probiotics, regulate the microecological balance in the intestine, promote the absorption of trace elements, enhance the movement function of the spleen and the stomach, accelerate the absorption of drug effect, improve the balance of microbiota or enzyme on the surface of the mucous membrane, or stimulate the specific or non-specific immune mechanism of the organism, and improve the planting resistance or the immunity of the organism; xing, etc. uses bifidobacteria and lactobacilli to pre-treat the liver ischemia reperfusion rat, which can obviously reduce the level of enterogenic endotoxemia and prevent the occurrence of liver injury; selective intestinal decontamination is also an important measure for adjusting intestinal microecology, and research and application of rifaximin (rifaximin), which is an antibiotic not absorbed by intestinal tracts, can enhance resistance by inhibiting the growth of urease and ammonia-producing bacteria in the intestinal tracts;
the multiple probiotics of the invention all adopt microencapsulated probiotics, except streptococcus thermophilus, wherein the ratio of bifidobacteria: is one, several or all of bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis and bifidobacterium longum; the lactobacillus refers to: one, several or all of lactobacillus acidophilus powder, lactobacillus casei, lactobacillus bulgaricus, lactobacillus delbrueckii, lactobacillus subspecies lactis, lactobacillus fermentum, lactobacillus helveticus, lactobacillus salivarius, lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei and lactobacillus johnsonii are mixed;
5. carbohydrate: carbohydrate is composed of three elements of carbon, hydrogen and oxygen, is the cheapest nutrient of three main nutrients for providing heat energy for human bodies, can be quickly oxidized in vivo to provide energy in time when being taken sufficiently, avoids using precious protein to provide energy, is also an important component of glycoprotein of cell membranes, glycolipid of nervous tissues and deoxyribonucleic acid (DNA) for transmitting genetic information, and contains glycogen which has strong detoxifying capacity for certain toxic chemical substances and toxins produced by various pathogenic microorganisms by liver cells when being sufficiently stored in liver;
the carbohydrate is one, several or all of L-arabinose, glucose, fructose, galactose, lactose, glucose, maltose, water-soluble dietary fiber, starch and glycogen;
6. amino acids
The essential amino acid and the nonessential amino acid are divided into essential amino acid and nonessential amino acid, are basic units for forming protein, and endow the protein with specific molecular structure form so as to have biochemical activity; taking a proper amount of methionine is helpful for the metabolism of various sulfur-containing compounds in human body, and the methyl contained in the methionine methylates toxicant or medicine to play a role in detoxification; leucine can repair muscles, control blood sugar and provide energy for body tissues, the essential amino acid phenylalanine can inhibit the growth of cancer and tumor and can reduce the toxic and side effects of the medicine, and lysine can improve the absorption and utilization of food protein, thereby achieving balanced nutrition and promoting growth and development; arginine helps to convert ammonia in the blood into urea for excretion; has effects in treating hyperammonemia, liver dysfunction, etc.; histidine reduces gastric acidity, relieves pain of gastrointestinal operation, relieves vomiting and burning sensation in stomach during pregnancy, inhibits digestive tract ulceration caused by vegetative nerve tension, and has effects on allergic diseases such as asthma; tryptophan can prevent pellagra and depression, improve sleep and regulate mood;
the amino acid refers to one, several or all of L-glutamine, methionine, isoleucine, tyrosine, phenylalanine, lysine, arginine, histidine, tryptophan, citrulline, ornithine and taurine;
7. fat powder
Fat, commonly known as grease, consists of elements of carbon, hydrogen and oxygen; it is not only an important component of human tissue, but also one of the main substances providing heat; the fat in the food is digested in the intestines and stomach, and most of the fat is converted into the fat again after being absorbed; it is mainly distributed in subcutaneous tissues, omentum majus, mesentery, periphery of kidney and the like of human body; the fat is triacylglycerol composed of glycerol and fatty acid, wherein the molecule of the glycerol is relatively simple, and the type and length of the fatty acid are different; fatty acids fall into three broad categories: saturated fatty acid, monounsaturated fatty acid and polyunsaturated fatty acid, wherein the source of the fat can be two of the following types: animal origin: fat stored in animal body: such as lard, beef tallow, mutton fat, fish oil, bone marrow, fat meat, cod liver oil, etc.; fat in animal milk: such as butter oil, vegetable origin: the plant fat source is mainly extracted from fruits of plants, such as sesame, sunflower seeds, tea, walnut, pine nut, soybean, etc.; through the compounding of various fatty acids, the content ratio of saturated fatty acid, monounsaturated fatty acid and polyunsaturated fatty acid is adjusted to be 1:1:1, and the ratio of omega-6 to omega-3 is 10: 1-2: 1, preferably 5: 1-2: 1, and most preferably 2: 1; 2-8 parts of omega-3 fatty acid is particularly added, the source of the omega-3 fatty acid comprises one or the combination of fish oil and algae oil, the embedding material is added, the mixture is homogenized to obtain emulsion, the emulsion is dried in spray drying equipment, and then the fat powder is obtained by screening;
the fat powder refers to one, several or all of MCT powder, alpha-linolenic acid, linoleic acid, corn oil, soybean oil, peanut oil, sunflower seed oil, olive oil, linseed oil and germ oil;
8. vitamins and minerals
The vitamins and the minerals are essential nutrients for human bodies, and the vitamins and the minerals added in the invention are essential nutrients for human bodies;
the added vitamins in the invention are one, several or all of vitamin A, vitamin D, vitamin E, vitamin K1, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, choline and biotin;
the mineral added in the invention is one, several or all of calcium, phosphorus, potassium, sodium, magnesium, chlorine, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium and molybdenum, and the mineral added in the invention is an organic or inorganic compound of the mineral;
the vitamin and mineral mixture added in the invention is a mixture obtained by mixing according to the principle of an equivalent increasing method and a specific mixing process, wherein the mixing speed is 12-15r/min, and the mixing time is 20-40 min;
9. the invention relates to a key technology of industrial production, which is formed by an integrated innovative method of microcapsule, semi-bionic or biological enzymolysis and ultrasonic extraction, vacuum concentration, alcohol precipitation or ultrafiltration to remove impurities and pesticide residues, and spray drying; the micro-encapsulation protection technology effectively solves the problem of inactivation of probiotics by high temperature and strong acid gastric juice in the oral administration process; adopting three-layer protein deep-embedding microcapsule technology, carrying out semi-bionic or biological enzymolysis and ultrasonic extraction, carrying out vacuum concentration, carrying out alcohol precipitation or ultrafiltration to remove impurities and pesticide residues, extracting and uniformly mixing the traditional Chinese medicine extract after microencapsulation treatment; the integrated innovative process is adopted to uniformly mix various ingredients to prepare powdery solid beverage and granules, the powdery solid beverage and the granules are subpackaged into 10 g/bag, and the granules are dissolved by about 150ml of warm boiled water (45 ℃) and then directly drunk or fed through nose for ingestion; or adding proper amount of auxiliary materials to prepare capsules and tablets or adding a sweetening agent and black sesame powder to prepare biscuits and other quick and convenient foods which are convenient to carry and eat outside, omitting spray drying and adding few auxiliary materials if the foods are prepared into beverages, subpackaging the beverages into 10-65 ml/bottle, drinking 1 bottle 0.5 hour each day in the morning, at noon and at night, and carrying out all operations in a clean and dry environment meeting the requirements of good production specifications of special medical purpose formula foods; the preparation method comprises mixing the Chinese medicinal extract, prebiotics, short peptide, multiple probiotics, and carbohydrate for the first time at a mixing rate of 30-45r/min for 20-40 min; then adding the mixture by a strict specific mixing process: pasteurization of the compound vitamins and minerals with mixing speed of 12-15r/min and mixing time of 20-40min for 1 hour to obtain a uniformly mixed powdery preparation;
the characteristics of the special food in the formula and the effect on the body are mainly shown in the following aspects:
1. the prebiotics and the probiotics contained in the formula inhibit the growth of putrefying bacteria by promoting the growth and the reproduction of intestinal probiotics, and form a protective barrier on the surface of intestinal mucosa, so that the damage of the intestinal putrefying bacteria to the intestinal mucosa can be resisted, the absorption of harmful substances in the intestine can be reduced, the intestinal peristalsis can be promoted, the discharge of residual substances in the intestine can be accelerated, the immunity of the organism can be enhanced by promoting the growth and the reproduction of the intestinal probiotics, and bioactive substances such as short peptides, carbohydrates, active polysaccharides and the like have synergistic effect;
2. the food formula of the invention takes food-derived bioactive short peptides with various sources as nitrogen sources, and the short peptides can be absorbed without being digested, so that the food formula is more beneficial to the utilization of organisms, can effectively improve the negative nitrogen balance of puerperal lactation promoting crowds, and the food-derived short peptides can improve the structure and the function of intestinal mucosa epithelial cells and improve the absorption capacity of intestinal mucosa;
3. the traditional Chinese medicine extract contained in the formula can regulate the body function and enhance the resistance; invigorating qi, promoting blood circulation, invigorating spleen and stomach, dredging collaterals, promoting lactation, promoting diuresis, promoting lactation, regulating blood circulation, and enhancing immunity; the intake of various impurities is reduced, and the liver and kidney burden is reduced;
4. the carbohydrate contained in the formula of the invention is also an important component of glycoprotein of cell membrane, glycolipid of nervous tissue and deoxyribonucleic acid (DNA) for transmitting genetic information, and when the carbohydrate is sufficiently stored in liver, the glycogen contained in the carbohydrate has strong detoxification capability to some toxic chemical substances and toxin produced by various pathogenic microorganisms;
4. the formula food contains various vitamins and minerals, can quickly supplement micronutrients required by consumers, and increases the absorption rate of mineral elements after the short peptides are chelated with calcium, iron, zinc and the like.
The integrated innovative preparation method comprises the following steps: step 1, semi-bionic ultrasonic extraction is carried out, accelerated motion of medicinal material substance molecules is realized by utilizing the characteristics of ultrasonic waves, and then the penetration force of liquid medicine is improved, so that the extraction efficiency is improved, the ultrasonic extraction is a physical extraction process, the chemical properties and the structures of active ingredients in medicinal materials are generally not changed, step 2, after the extract is subjected to vacuum concentration, impurities and pesticide residues are removed by an alcohol precipitation or ultrafiltration method to purify the extract, step 3, a herbal essence microencapsulation protection technology is manufactured by an integrated innovative method of spray drying, and the inactivation of high temperature and strong acid gastric juice to probiotics in an oral taking process is effectively solved; the world technical problem of the combined action of the sterilization function of the traditional Chinese medicine and probiotics is solved by adopting a three-layer protein deep-buried microcapsule technology, integrating an innovative preparation method with the aim of the invention and adopting a preparation process of uniformly mixing the microencapsulated traditional Chinese medicine extract.
Detailed Description
The invention is further illustrated by the following examples, which will assist in understanding the invention;
the lactation promotion aim of the invention is realized by combining the physical characteristics of postpartum hypogalactia patients, according to the marrow theory of traditional Chinese medicine, the gold is matched with food which is prepared by taking more than 2 traditional Chinese medicine extract essences which can be used as both medicine and food, a plurality of probiotics and short peptide as main raw materials and taking prebiotics, carbohydrates, amino acids, a plurality of vitamins and a plurality of mineral substances as auxiliary materials; the Bifidobacterium is selected from one or more of Bifidobacterium adolescentis, Bifidobacterium lactis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, and Bifidobacterium longum; the lactobacillus is selected from one or more of Lactobacillus acidophilus powder, Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus delbrueckii, Lactobacillus subspecies lactis, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus salivarius, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus johnsonii; the short peptide is selected from one or more of marine fish oligopeptide, marine osteopeptide, soybean protein peptide, whey protein peptide and egg albumin peptide; the prebiotics is selected from one or more of isomaltooligosaccharide, stachyose, fructo-oligosaccharide, soybean oligosaccharide and xylo-oligosaccharide; the fat powder is selected from one or more of MCT powder, alpha-linolenic acid, linoleic acid, corn oil, soybean oil, peanut oil, sunflower seed oil, olive oil, linseed oil and germ oil; the amino acid is selected from one or more of methionine, isoleucine, tyrosine, phenylalanine, lysine, arginine, histidine, tryptophan, citrulline, ornithine and taurine; the vitamin premix is one or more selected from vitamin A, vitamin D, vitamin E, vitamin K1, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, choline, biotin, etc.; the mineral premix is selected from one or more of calcium, phosphorus, potassium, sodium, magnesium, ferrum, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum, etc.;
the integrated innovative preparation method comprises the following steps: step 1, semi-bionic ultrasonic extraction is carried out, accelerated motion of medicinal material substance molecules is realized by utilizing the characteristics of ultrasonic waves, and then the penetration force of liquid medicine is improved, so that the extraction efficiency is improved, the ultrasonic extraction is a physical extraction process, the chemical properties and the structures of active ingredients in medicinal materials are generally not changed, step 2, after the extract is subjected to vacuum concentration, impurities and pesticide residues are removed by an alcohol precipitation or ultrafiltration method to purify the extract, step 3, a herbal essence microencapsulation protection technology is manufactured by an integrated innovative method of spray drying, and the inactivation of high temperature and strong acid gastric juice to probiotics in an oral taking process is effectively solved; the world technical problem of the combined action of the sterilization function of the traditional Chinese medicine and probiotics is solved by adopting a three-layer protein deep-buried microcapsule technology, integrating an innovative preparation method with the aim of the invention and adopting a preparation process of uniformly mixing the microencapsulated traditional Chinese medicine extract. Example one
The following formula and proportion are selected to prepare the special postpartum lactation-promoting diet for the puerperal hypogalactia patients, and more than 6 kinds of the extracts which can be used as both medicine and food are selected according to the following raw materials: 5 parts of astragalus membranaceus, 5 parts of processed pangolin, 5 parts of uniflower swisscentaury root, 5 parts of cowherb seed, 5 parts of parasitic loranthus, 5 parts of pangolin, 5 parts of beautiful sweetgum fruit, 5 parts of codonopsis pilosula, 5 parts of akebia stem, 5 parts of prepared rehmannia root, 5 parts of ligusticum wallichii, 5 parts of eucommia ulmoides, 5 parts of ricepaperplant pith, 5 parts of motherwort, 3 parts of donkey-hide gelatin, 3 parts of angelica, 3 parts of ginseng, 3 parts of luffa kernel, 3 parts of luffa sponge, 3 parts of pawpaw, 3 parts of Chinese date, 3 parts of corn stigma, 3 parts of platycodon grandiflorum, 3 parts of phaseolus calcaratus, 3 parts of fructus amomi, 3 parts of dried orange peel, 3 parts of cinnamon, 3 parts of raspberry, 3 parts of Chinese yam, 1 part of; 80 parts of micro-encapsulated bifidobacteria, 80 parts of lactobacillus, 440 parts of streptococcus thermophilus, 100 parts of L-glutamine, 50 parts of gamma-aminobutyric acid, 130 parts of short peptide, 100 parts of prebiotics, 50 parts of compound amino acid, 80 parts of pine grain dietary fiber, 130 parts of fat powder, 5 parts of compound vitamin and 50 parts of compound mineral substance;
more than 6 kinds of the following raw materials can be selected as medicine and food during the preparation: astragalus, processed pangolin scales, uniflower swisscentaury root, cowherb seed, Chinese taxillus twig, pangolin scales, beautiful sweetgum fruit, pilose asiabell root, akebia stem, prepared rehmannia root, szechuan lovage rhizome, eucommia bark, ricepaper pith, motherwort herb, donkey-hide gelatin, ginseng, Chinese angelica, towel gourd seed, loofah sponge, pawpaw, Chinese date, corn stigma, platycodon root, red bean, villous amomum fruit, tangerine peel, cassia bark, raspberry, Chinese yam, common fennel fruit, honeysuckle flower, liquoric root, dandelion, kudzuvine root, day lily and medlar are extracted by adopting semi-bionic or biological enzymolysis and ultrasonic wave, and then are subjected to vacuum concentration, alcohol precipitation or ultrafiltration to; and mixing with oligopeptide, prebiotics, amino acid, water-soluble dietary fiber, MCT powder, alpha-linolenic acid, linoleic acid, bifidobacteria (bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis and bifidobacterium longum), lactobacillus (lactobacillus acidophilus powder, lactobacillus casei, lactobacillus bulgaricus, lactobacillus delbrueckii, lactobacillus subspecies lactis, lactobacillus fermentum, lactobacillus helveticus, lactobacillus salivarius, lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei and lactobacillus johnsonii thermophilus), compound vitamin and mineral substances extracted by biological enzymolysis for 20min at a mixing rate of 45r/min to obtain a uniformly mixed powdery preparation product.
Example two
The following formula and proportion are selected to prepare the special postpartum lactation-promoting diet for the puerperal hypogalactia patients, and the special postpartum lactation-promoting diet is prepared by mixing the following components: the extract can be used as both medicine and food: 15 parts of full cream milk powder, 20 parts of whey protein powder, 13 parts of edible plant water extract concentrated powder (10 parts of pawpaw, 10 parts of raspberry, 10 parts of Chinese date, 8 parts of fennel, 8 parts of longan, 8 parts of corn stigma, 8 parts of dried orange peel, 6 parts of Chinese yam, 6 parts of liquorice, 5 parts of dandelion, 5 parts of kudzu root and 5 parts of medlar), 15 parts of compound probiotics (maltodextrin, bifidobacterium lactis, bifidobacterium longum, bifidobacterium bifidum, lactobacillus acidophilus, lactobacillus rhamnosus and lactobacillus plantarum), 10 parts of lactose, 10 parts of weever powder, 2 parts of fructose, 2 parts of brown sugar, 3 parts of marine fish oligopeptide powder, 3 parts of L-glutamine, resistant dextrin, 2 parts of inulin, 2 parts of powdered oil 2 (linseed oil, sunflower seed oil, starch sodium octenyl succinate, maltodextrin and silicon dioxide), trehalose, vitamin A acetate, cholecalciferol, dl-alpha-tocopherol acetate and phytomenaquinone, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamin, L-ascorbic acid, nicotinic acid, folic acid, calcium pantothenate, biotin, choline bitartrate, magnesium oxide, calcium carbonate, ferric pyrophosphate, zinc gluconate, sodium selenite, (DHA) docosahexaenoic acid.
The integrated innovative preparation method comprises the following steps: step 1, semi-bionic ultrasonic extraction is carried out, accelerated motion of medicinal material substance molecules is realized by utilizing the characteristics of ultrasonic waves, and then the penetration force of liquid medicine is improved, so that the extraction efficiency is improved, the ultrasonic extraction is a physical extraction process, the chemical properties and the structures of active ingredients in medicinal materials are generally not changed, step 2, after the extract is subjected to vacuum concentration, impurities and pesticide residues are removed by an alcohol precipitation or ultrafiltration method to purify the extract, step 3, a herbal essence microencapsulation protection technology is manufactured by an integrated innovative method of spray drying, and the inactivation of high temperature and strong acid gastric juice to probiotics in an oral taking process is effectively solved; the world technical problem of the combined action of the sterilization function of the traditional Chinese medicine and probiotics is solved by adopting a three-layer protein deep-buried microcapsule technology, integrating an innovative preparation method with the aim of the invention and adopting a preparation process of uniformly mixing the microencapsulated traditional Chinese medicine extract.
Clinical research
After long-term use, the health-care product is found to have a good conditioning effect on the bodies of puerperal lactation promoting people; clinical studies will be conducted in 2020 by other medical institutions organized by the national institute of health and science and technology (i.e. my company will step down the data of clinical studies during the patent examination phase).
Claims (2)
1. The special lactation promoting diet for postpartum puerperae is characterized by comprising the following raw materials in parts by weight: more than 6 kinds of medicinal and edible extracts are selected from the following raw materials: 5 parts of astragalus membranaceus, 5 parts of processed pangolin, 5 parts of uniflower swisscentaury root, 5 parts of cowherb seed, 5 parts of parasitic loranthus, 5 parts of pangolin, 5 parts of beautiful sweetgum fruit, 5 parts of codonopsis pilosula, 5 parts of akebia stem, 5 parts of prepared rehmannia root, 5 parts of ligusticum wallichii, 5 parts of eucommia ulmoides, 5 parts of ricepaperplant pith, 5 parts of motherwort, 3 parts of donkey-hide gelatin, 3 parts of angelica, 3 parts of ginseng, 3 parts of luffa kernel, 3 parts of luffa sponge, 3 parts of pawpaw, 3 parts of Chinese date, 3 parts of corn stigma, 3 parts of platycodon grandiflorum, 3 parts of phaseolus calcaratus, 3 parts of fructus amomi, 3 parts of dried orange peel, 3 parts of cinnamon, 3 parts of raspberry, 3 parts of Chinese yam, 1 part of; 80 parts of micro-encapsulated bifidobacteria, 80 parts of lactobacillus, 440 parts of streptococcus thermophilus, 100 parts of L-glutamine, 50 parts of gamma-aminobutyric acid, 130 parts of short peptide, 100 parts of prebiotics, 50 parts of compound amino acid, 80 parts of pine grain dietary fiber, 130 parts of fat powder, 5 parts of compound vitamin and 50 parts of compound mineral substance; more than 6 kinds of the following raw materials can be selected as medicine and food during the preparation: astragalus, processed pangolin scales, uniflower swisscentaury root, cowherb seed, Chinese taxillus twig, pangolin scales, beautiful sweetgum fruit, pilose asiabell root, akebia stem, prepared rehmannia root, szechuan lovage rhizome, eucommia bark, ricepaper pith, motherwort herb, donkey-hide gelatin, ginseng, Chinese angelica, towel gourd seed, loofah sponge, pawpaw, Chinese date, corn stigma, platycodon root, red bean, villous amomum fruit, tangerine peel, cassia bark, raspberry, Chinese yam, common fennel fruit, honeysuckle flower, liquoric root, dandelion, kudzuvine root, day lily and medlar are extracted by adopting semi-bionic or biological enzymolysis and ultrasonic wave, and then are subjected to vacuum concentration, alcohol precipitation or ultrafiltration to; and mixing with oligopeptide, prebiotics, amino acid, water-soluble dietary fiber, MCT powder, alpha-linolenic acid, linoleic acid, bifidobacteria (bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis and bifidobacterium longum), lactobacillus (lactobacillus acidophilus powder, lactobacillus casei, lactobacillus bulgaricus, lactobacillus delbrueckii, lactobacillus subspecies lactis, lactobacillus fermentum, lactobacillus helveticus, lactobacillus salivarius, lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei and lactobacillus johnsonii thermophilus), compound vitamin and mineral substances extracted by biological enzymolysis for 20min at a mixing rate of 45r/min to obtain a uniformly mixed powdery preparation product.
2. The puerperal postpartum lactation promoting special diet according to claim 1, further comprising the following components by weight: 15 parts of full cream milk powder, 20 parts of whey protein powder, 13 parts of edible plant water extract concentrated powder (10 parts of pawpaw, 10 parts of raspberry, 10 parts of Chinese date, 8 parts of fennel, 8 parts of longan, 8 parts of corn stigma, 8 parts of dried orange peel, 6 parts of Chinese yam, 6 parts of liquorice, 5 parts of dandelion, 5 parts of kudzu root and 5 parts of medlar), 15 parts of compound probiotics (maltodextrin, bifidobacterium lactis, bifidobacterium longum, bifidobacterium bifidum, lactobacillus acidophilus, lactobacillus rhamnosus and lactobacillus plantarum), 10 parts of lactose, 10 parts of weever powder, 2 parts of fructose, 2 parts of brown sugar, 3 parts of marine fish oligopeptide powder, 3 parts of L-glutamine, resistant dextrin, 2 parts of inulin, 2 parts of powdered oil 2 (linseed oil, sunflower seed oil, starch sodium octenyl succinate, maltodextrin and silicon dioxide), trehalose, vitamin A acetate, cholecalciferol, dl-alpha-tocopherol acetate and phytomenaquinone, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamin, L-ascorbic acid, nicotinic acid, folic acid, calcium pantothenate, biotin, choline bitartrate, magnesium oxide, calcium carbonate, ferric pyrophosphate, zinc gluconate, sodium selenite, (DHA) docosahexaenoic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010665559.1A CN111955720A (en) | 2020-07-11 | 2020-07-11 | Special postpartum lactation-promoting diet for puerpera and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010665559.1A CN111955720A (en) | 2020-07-11 | 2020-07-11 | Special postpartum lactation-promoting diet for puerpera and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111955720A true CN111955720A (en) | 2020-11-20 |
Family
ID=73362307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010665559.1A Pending CN111955720A (en) | 2020-07-11 | 2020-07-11 | Special postpartum lactation-promoting diet for puerpera and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111955720A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113100359A (en) * | 2021-04-13 | 2021-07-13 | 上海灿世生物科技有限公司 | Polypeptide protein nutrition compound beverage for puerpera in lactation period |
CN113287686A (en) * | 2021-06-09 | 2021-08-24 | 广西壮族自治区水牛研究所 | Buffalo lactation promoting feed |
CN114601163A (en) * | 2022-03-29 | 2022-06-10 | 陇东学院 | Daylily extract and preparation method and application thereof |
CN114958694A (en) * | 2022-07-06 | 2022-08-30 | 福建生物工程职业技术学院 | Lactobacillus rhamnosus for co-producing conjugated linoleic acid and gamma-aminobutyric acid and application thereof |
-
2020
- 2020-07-11 CN CN202010665559.1A patent/CN111955720A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113100359A (en) * | 2021-04-13 | 2021-07-13 | 上海灿世生物科技有限公司 | Polypeptide protein nutrition compound beverage for puerpera in lactation period |
CN113287686A (en) * | 2021-06-09 | 2021-08-24 | 广西壮族自治区水牛研究所 | Buffalo lactation promoting feed |
CN114601163A (en) * | 2022-03-29 | 2022-06-10 | 陇东学院 | Daylily extract and preparation method and application thereof |
CN114601163B (en) * | 2022-03-29 | 2024-02-02 | 陇东学院 | Daylily extract and preparation method and application thereof |
CN114958694A (en) * | 2022-07-06 | 2022-08-30 | 福建生物工程职业技术学院 | Lactobacillus rhamnosus for co-producing conjugated linoleic acid and gamma-aminobutyric acid and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111955720A (en) | Special postpartum lactation-promoting diet for puerpera and preparation method thereof | |
CN104223074A (en) | Total-nutrition formula food for preventing constipation | |
CN105533705A (en) | Medical formula food for recuperating women during second trimester | |
CN104839683A (en) | Medical formula food for people with constipation | |
CN108968037A (en) | Senile dementia full nutrition formula food | |
CN104839684A (en) | Medical formula food for people with helicobacter pylori related gastritis | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN104187651A (en) | High-uric-acid prevention total-nutrition formula food | |
CN107334156A (en) | Lactagogue full nutrition formula food | |
CN105326038A (en) | Pregnant-woman pregnancy-vomiting total-nutrient formula food | |
CN105380263A (en) | Full-nutrition formula food for treating pregnant woman constipation | |
CN107319550A (en) | Brain trauma full nutrition formula food | |
CN104839652A (en) | Postpartum recuperation medicine formula food for puerperas | |
CN104187637A (en) | Full-nutritional formula food for tonifying Yang | |
CN104187643A (en) | All-nutrition formula food for yang-deficiency constitution | |
CN108936607A (en) | Chronic Obstructive Pulmonary Disease full nutrition formula food | |
CN104839673A (en) | Medical formula food for people with renal failure | |
CN104839666A (en) | Medical formula food for prostatitis | |
CN104839642A (en) | Ovarian cancer medicine formula food | |
CN104256656A (en) | Full-nutrition formulated food for fatty acid metabolic disorder | |
CN104187721A (en) | Total nutrient formula food for cardiovascular diseases | |
CN104207148A (en) | Cervical cancer full nutrient formula food | |
CN108618140A (en) | The antenatal conditioning medicine formula food of pregnant woman | |
CN104839671A (en) | Medicine formula food for tonifying Yang | |
CN105029406A (en) | Medical formula food for hysteromyoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201120 |
|
WD01 | Invention patent application deemed withdrawn after publication |